A COMPARATIVE STUDY BETWEEN MIFEPRISTONE VS. PLACEBO AS AN UTERINE SENSITIZER FOR SECOND TRIMESTER ABORTIONS
Introduction: Mifepristone can be used prior to prostaglandins as an uterine sensitizer in second trimester abortion. This accelerates the expulsion of fetus. This study was done to compare the efficacy and side effects of using oral mifepristone tablet vs placebo 24 hours prior to induction of sec...
| Published in: | National Journal of Medical Research |
|---|---|
| Main Authors: | Meetali Parashar, Kiran Trivedi, Sashi Bala Singh, Rajesh Kumar |
| Format: | Article |
| Language: | English |
| Published: |
Medsci Publications
2019-12-01
|
| Subjects: | |
| Online Access: | http://njmr.in/index.php/file/article/view/139 |
Similar Items
Comparison of Two Different Intervals of Misoprostol Administration in Second Trimester Abortions
by: Anjali Gupta, et al.
Published: (2023-06-01)
by: Anjali Gupta, et al.
Published: (2023-06-01)
Mifepristone and Misoprostol Induced Abortion with A Large Myomatous Uterus
by: Yiu-Tai Li, et al.
Published: (2005-06-01)
by: Yiu-Tai Li, et al.
Published: (2005-06-01)
Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
by: Tariku Shimels, et al.
Published: (2023-03-01)
by: Tariku Shimels, et al.
Published: (2023-03-01)
Concurrent Use of Mifepristone and Misoprostol for Early Medical Abortion
by: Yiu-Tai Li, et al.
Published: (2006-12-01)
by: Yiu-Tai Li, et al.
Published: (2006-12-01)
Use of Mifepristone and Sublingual Misoprostol for Early Medical Abortion
by: Mau Lin, et al.
Published: (2006-12-01)
by: Mau Lin, et al.
Published: (2006-12-01)
Comparative study of sublingual versus vaginal misoprostol following mifepristone in early first trimester medical termination of pregnancy - a prospective study
by: B. L Pathak, et al.
Published: (2019-01-01)
by: B. L Pathak, et al.
Published: (2019-01-01)
Monitoring Medical Abortion Using Mifepristone/Misoprostol Combination with Ultrasonogram and Serum Human Chorionic Gonadotropin
by: Szu-Yuan Chou, et al.
Published: (2006-03-01)
by: Szu-Yuan Chou, et al.
Published: (2006-03-01)
Simultaneous use of mifepristone and misoprostol for early pregnancy termination
by: Yiu-Tai Li, et al.
Published: (2011-03-01)
by: Yiu-Tai Li, et al.
Published: (2011-03-01)
A randomized comparison of three early medical abortion regimes: Mifepristone and misoprostol, misoprostol alone and methotrexate and misoprostol
by: Renuka Brijwal, et al.
Published: (2025-07-01)
by: Renuka Brijwal, et al.
Published: (2025-07-01)
Comparison of sequential vaginal and sublingual misoprostol after a vaginal loading dose for second-trimester abortion
by: Ming-Chao Huang, et al.
Published: (2017-06-01)
by: Ming-Chao Huang, et al.
Published: (2017-06-01)
Efficacy of Mifepristone/Misoprostol Combination for Medical Abortion Determined by Detection of Retained Products in a Community Hospital in Taipei, Taiwan
by: Szu-Yuan Chou, et al.
Published: (2004-06-01)
by: Szu-Yuan Chou, et al.
Published: (2004-06-01)
A prospective study on the effectiveness of a combination regime (Mifepristone and Misoprostol) in comparison with Misoprostol for missed abortion
by: Nidhi Gupta, et al.
Published: (2023-10-01)
by: Nidhi Gupta, et al.
Published: (2023-10-01)
Induction of abortion in the first trimester of pregnancy using letrozole and misoprostol combination versus misoprostol alone - A comparative observational study
by: Swarnali Biswas, et al.
Published: (2024-01-01)
by: Swarnali Biswas, et al.
Published: (2024-01-01)
To Study the Efficacy of Intraamniotic Prostaglandin F2 Alpha versus Mifepristone and Misoprostol Combination for Mid-trimester Medical Termination of Pregnancy
by: NM Anupam Kapur, et al.
Published: (2024-08-01)
by: NM Anupam Kapur, et al.
Published: (2024-08-01)
Differences in pain, bleeding, and satisfaction during medical abortion at very early gestations
by: Frida Gyllenberg, et al.
Published: (2025-09-01)
by: Frida Gyllenberg, et al.
Published: (2025-09-01)
High-Dose Misoprostol as An Alternative Therapy After Failed Medical Abortion
by: Yiu-Tai Li, et al.
Published: (2008-12-01)
by: Yiu-Tai Li, et al.
Published: (2008-12-01)
Outpatient medical management of later second trimester abortion (18–23.6 weeks) with procedural evacuation backup: A large case series
by: Sruthi Chandrasekaran, et al.
Published: (2024-01-01)
by: Sruthi Chandrasekaran, et al.
Published: (2024-01-01)
Effectiveness and Safety of Medical Abortion with Mifepristone and Sublingual Misoprostol up to 63 Days of Gestation
by: Prakasit Saengbanyang, et al.
Published: (2024-09-01)
by: Prakasit Saengbanyang, et al.
Published: (2024-09-01)
Association of Obstetrical Variables with Induction to Expulsion Interval in Misoprostol-Induced Mid-Trimester Abortion
by: Bushra Iftikhar, et al.
Published: (2017-06-01)
by: Bushra Iftikhar, et al.
Published: (2017-06-01)
Induction of Labor Using Misoprostol With or Without Mifepristone in Intrauterine Deat
by: Ajay Agrawal, et al.
Published: (2014-06-01)
by: Ajay Agrawal, et al.
Published: (2014-06-01)
Landscape assessment of the availability of medical abortion medicines in India
by: Priya Karna, et al.
Published: (2024-06-01)
by: Priya Karna, et al.
Published: (2024-06-01)
A Comparative Study of Vaginal Misoprostol and High Dose Intravenous Oxytocin for Second Trimester Pregnancy Termination
by: Minoo Rajaee, et al.
Published: (2010-06-01)
by: Minoo Rajaee, et al.
Published: (2010-06-01)
Medicamentous abortion with mifepristone and misoprostol in Serbia and Montenegro
by: Stojnić Jelena, et al.
Published: (2006-01-01)
by: Stojnić Jelena, et al.
Published: (2006-01-01)
Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities
by: Amy Grossman, et al.
Published: (2023-04-01)
by: Amy Grossman, et al.
Published: (2023-04-01)
Short‐term efficacy and safety of early medical abortion in Japan: A multicenter prospective study
by: Yutaka Osuga, et al.
Published: (2023-01-01)
by: Yutaka Osuga, et al.
Published: (2023-01-01)
ALTERNATIVE APPROACHES TO MEDICAL ABORTION
by: K. Telbiyska, et al.
Published: (2024-03-01)
by: K. Telbiyska, et al.
Published: (2024-03-01)
Partial Hydatidiform Mole in a Medical Abortion with the Mifepristone/Misoprostol Combination
by: Pui-Ki Chow, et al.
Published: (2004-12-01)
by: Pui-Ki Chow, et al.
Published: (2004-12-01)
Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death
by: Damyanti Sharma, et al.
Published: (2011-09-01)
by: Damyanti Sharma, et al.
Published: (2011-09-01)
Self-managed medication abortion outcomes: results from a prospective pilot study
by: Heidi Moseson, et al.
Published: (2020-10-01)
by: Heidi Moseson, et al.
Published: (2020-10-01)
A descriptive summary of the WHO availability assessments of medical abortion medicines in eight African countries
by: Amy Grossman, et al.
Published: (2024-12-01)
by: Amy Grossman, et al.
Published: (2024-12-01)
Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial
by: Charlotte Hamel, et al.
Published: (2021-02-01)
by: Charlotte Hamel, et al.
Published: (2021-02-01)
Evaluating women’s acceptability of treatment of incomplete second trimester abortion using misoprostol provided by midwives compared with physicians: a mixed methods study
by: Susan Atuhairwe, et al.
Published: (2022-11-01)
by: Susan Atuhairwe, et al.
Published: (2022-11-01)
Comparison of the Effect of Letrozole and Misoprostol versus Misoprostol Alone on First Trimester Abortion
by: M Mokhtari, et al.
Published: (2023-03-01)
by: M Mokhtari, et al.
Published: (2023-03-01)
Inducing labor after fetal demise: a systematic review and meta-analysis of the efficacy and safety of mifepristone and misoprostol combination versus misoprostol alone
by: Maryam Shami, et al.
Published: (2025-04-01)
by: Maryam Shami, et al.
Published: (2025-04-01)
An Experience with Misoprostol for the Induction of First Trimester Abortions in a Secondary Hospital in South Africa
by: J. Fuchs, et al.
Published: (2000-12-01)
by: J. Fuchs, et al.
Published: (2000-12-01)
Safety of mifepristone in medical abortion in hyperthyroidism pregnant mice
by: Yun-Hui Tang, et al.
Published: (2019-01-01)
by: Yun-Hui Tang, et al.
Published: (2019-01-01)
Acceptability of misoprostol-only medication abortion dispensed by mail-order or retail pharmacy: a qualitative study based on in-depth interviews in the United States
by: Dana M. Johnson, et al.
Published: (2025-12-01)
by: Dana M. Johnson, et al.
Published: (2025-12-01)
Effectiveness and acceptability of home use of misoprostol for medical abortion up to 10 weeks of pregnancy
by: Volodymyr Podolskyi, et al.
Published: (2023-05-01)
by: Volodymyr Podolskyi, et al.
Published: (2023-05-01)
Spatial Disparities in Mifepristone Use for Early Miscarriage and Induced Abortion Among Obstetrician–Gynecologists Practicing in Massachusetts
by: Emily Newton-Hoe, et al.
Published: (2024-04-01)
by: Emily Newton-Hoe, et al.
Published: (2024-04-01)
Efficacy of a four-drug combined regimen compared to uterine curettage in the treatment of incomplete medical abortion: a prospective observational study
by: Yanlin Feng, et al.
Published: (2025-04-01)
by: Yanlin Feng, et al.
Published: (2025-04-01)
Similar Items
-
Comparison of Two Different Intervals of Misoprostol Administration in Second Trimester Abortions
by: Anjali Gupta, et al.
Published: (2023-06-01) -
Mifepristone and Misoprostol Induced Abortion with A Large Myomatous Uterus
by: Yiu-Tai Li, et al.
Published: (2005-06-01) -
Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
by: Tariku Shimels, et al.
Published: (2023-03-01) -
Concurrent Use of Mifepristone and Misoprostol for Early Medical Abortion
by: Yiu-Tai Li, et al.
Published: (2006-12-01) -
Use of Mifepristone and Sublingual Misoprostol for Early Medical Abortion
by: Mau Lin, et al.
Published: (2006-12-01)
